
Compugen Ltd
@CompugenLtd
Followers
291
Following
46
Media
102
Statuses
123
From Code to Cure®: A leader in predictive drug target discovery advancing a pipeline of #immunotherapies for cancer. $CGEN
Holon, Israel
Joined May 2020
RT @OGConferences: The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen .
0
3
0
RT @nucleai_ai: We're thrilled to welcome Dr. Granit from @CompugenLtd to #NucleaiAcademy lecture series. Dive deep into the transformative….
0
3
0
RT @LifeSciAdvisors: Join us on May 23rd at 12pm ET for a KOL webinar with @CompugenLtd, featuring Drew Pardoll, MD, PhD (@dpardol1) discus….
0
2
0
RT @LifeSciAdvisors: Join us on May 23rd at 12pm ET for a KOL webinar with @CompugenLtd, featuring Drew Pardoll, MD, PhD (@dpardol1) discus….
0
2
0
RT @proactive_NA: $CGEN Compugen says it is pioneering a 'computational discovery approach' to cancer immunotherapy .
0
3
0
Our CEO Anat Cohen-Dayag speaks to @KarenJagoda about the computational approach powering our discovery and clinical development and its promise for cancer patients who've exhausted all other treatment options. Listen: #Immunooncology #TIGIT #PVRIG #DNAM1.
0
0
3
RT @rgranit: I’m excited to share that our recent research findings on the accurate #singlecellanalysis of #PVRIG and its corrected #genemo….
0
5
0
Proud of our CEO Dr. Anat Cohen-Dayag. Anat recently sat down w/ @Gold_pharma to discuss her career journey and @CompugenLtd's transformation to a clinical-stage cancer #immunotherapy company and pioneer in computational target discovery. Check out the article! #LeadershipMatters.
In GOLD's '5 minutes with Anat Cohen-Dayag, CEO, Compugen', Anat shares her thoughts on the challenges facing pharma CEOs today, the value of mentorship and why organisations need a diverse range of personality types. Read here: #compugen #mentorship.
0
1
3
Honored to be named Best Clinical-Stage Immuno-oncology Development Company by @Global_H_Pharma. This award recognizes the promise of our work on the DNAM-1 axis hypothesis, which positions us to lead in this new area of cancer immunotherapy. #DNAM1 #TIGIT
0
2
6
CEO @AnatDayag spoke with @NoCamels about the inequalities #womenintech face, including fewer leadership roles. We’re grateful for her dedication and are excited for our future with her at the helm. Read more: #womeninscience.
0
1
3
Compugen Still Confident Of Its TIGIT Strategy Despite Roche’s Setbacks
insights.citeline.com
Discover essential insights and analysis for the pharmaceutical industry with Scrip. Stay updated on trends, innovations, and market intelligence.
0
1
4
Compugen’s VP for Preclinical Development, will be presenting on PVRIG and TIGIT immune checkpoint blockade in cancer: Emerging translational data from clinical trials at the upcoming @congress_AIS #immunotherapy #immunooncology #ais2022
0
1
3
Compugen’s Henry Adewoye and Ari Krashin are delighted to be participating at this year’s JMP Securities LLC Life Sciences Conference in New York City. You can listen in live to the fireside chat moderated by Reni Benjamin by going to #checkpoint
0
1
7
Compugen's @AnatDayag and Ari Krashin are delighted to be participating at this year’s #JefferiesHealthcare Conference in New York City. You can listen in live to the fireside chat moderated by Chris Howerton, Ph.D. on #jefferies #immunotherapy
0
0
5
RT @CompugenLtd: Today, Compugen's Roy Granit is presenting at the Keystone Symposium: Cancer Immunotherapy: Decoding the Cancer Immunity I….
0
4
0
Today we will be presenting at the @oppenheimer 32nd Annual Healthcare Conference #OpcoHC22. For more details on the presentation click here: and be sure to check out the #webcast here:
0
2
5
On #InternationalWomensDay we are proud to have women representing 53% of our workforce and to be led by an inspiring female President and CEO, Anat Cohen-Dayag @AnatDayag #BreakTheBias #IWD2022
0
0
3